MedTrace Logo

Effect of Fish Oil on Plasma Triglycerides in Adults

NCT00804427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-02-22

No results posted yet for this study

Summary

The purpose of this small, short pilot study is to determine the feasibility (e.g., recruitment, dose acceptance, retention) of a future longer trial comparing the effects of two types of omega-3 fats from fish oil on plasma triglycerides. The two types of fish oil are composed of (1) omega-3 fatty acids in triglyceride form; and (2) as esterified free fatty acids (i.e. ethyl esters). Although these two types of fish oil supplements are available to the public, it remains unclear whether they are equally effective in lowering plasma triglycerides.

Conditions

  • Hypertriglyceridemia

Interventions

DIETARY_SUPPLEMENT

Fish oil (90% triglycerides)

DIETARY_SUPPLEMENT

Fish oil (60% triglycerides)

DIETARY_SUPPLEMENT

Fish oil (ethyl esters)

DIETARY_SUPPLEMENT

Soy oil

Sponsors & Collaborators

Principal Investigators

  • Christopher D Gardner · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-02-28
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00804427 on ClinicalTrials.gov